Search

everythinglearnresearchcommunity

for

Search:↓

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Inhibiting IL-17 and IL-23 improves wound healing in obese, diabetic mice by promoting healing macrophages.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

Tph cells are linked to the severity of systemic lupus erythematosus.

Skin bacteria can help wound healing by activating certain immune cells.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

EGFR deficiency in skin causes hair follicle issues and inflammation.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Targeting Vδ1+T-cells may help treat alopecia areata.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.